(Q35136117)

6 August 2017

1 reference

title

Tetrathiomolybdate anticopper therapy for Wilson's disease inhibits angiogenesis, fibrosis and inflammation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6740133&resulttype=core&format=json

12 May 2020

author name string

G J Brewer

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6740133&resulttype=core&format=json

12 May 2020

publication date

1 January 2003

1 reference

Journal of Cellular and Molecular Medicine

6 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6740133&resulttype=core&format=json

12 May 2020

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6740133&resulttype=core&format=json

12 May 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6740133&resulttype=core&format=json

12 May 2020

page(s)

11-20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6740133&resulttype=core&format=json

Recognition, diagnosis, and management of Wilson's disease

12 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2003.TB00198.X

Penicillamine, a new oral therapy for Wilson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2003.TB00198.X

Treatment of Wilson's disease with trientine (triethylene tetramine) dihydrochloride

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2003.TB00198.X

Treatment of Wilson's disease with zinc: XV long-term follow-up studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2003.TB00198.X

Worsening of neurologic syndrome in patients with Wilson's disease with initial penicillamine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2003.TB00198.X

Treatment of Wilson's disease with ammonium tetrathiomolybdate. I. Initial therapy in 17 neurologically affected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2003.TB00198.X

Treatment of Wilson disease with ammonium tetrathiomolybdate. II. Initial therapy in 33 neurologically affected patients and follow-up with zinc therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2003.TB00198.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2003.TB00198.X

Angiogenesis in cancer, vascular, rheumatoid and other disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2003.TB00198.X

Anticopper treatment inhibits pseudopodial protrusion and the invasive spread of 9L gliosarcoma cells in the rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2003.TB00198.X

The role of copper suppression as an antiangiogenic strategy in head and neck squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2003.TB00198.X

Radiotherapy and antiangiogenic TM in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2003.TB00198.X

Suppression of tumor recurrence and metastasis by a combination of the PHSCN sequence and the antiangiogenic compound tetrathiomolybdate in prostate carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2003.TB00198.X

Growth factor release from amylopectin hydrogel based on copper coordination

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2003.TB00198.X

Purified monocyte-derived angiogenic substance (angiotropin) stimulates migration, phenotypic changes, and "tube formation" but not proliferation of capillary endothelial cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2003.TB00198.X

Interaction of human angiogenin with copper modulates angiogenin binding to endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2003.TB00198.X

SPARC is a source of copper-binding peptides that stimulate angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2003.TB00198.X

Transforming growth factor beta in tissue fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2003.TB00198.X

SPARC regulates the expression of collagen type I and transforming growth factor-beta1 in mesangial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2003.TB00198.X

Tumor necrosis factor-alpha antagonists for the treatment of rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2003.TB00198.X

Copper deficiency in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2003.TB00198.X

Copper deficiency reversibly impairs DNA synthesis in activated T lymphocytes by limiting interleukin 2 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2003.TB00198.X

Connective tissue growth factor mediates transforming growth factor beta-induced collagen synthesis: down-regulation by cAMP

21 January 2018

1 reference

12 December 2020

Intraocular neovascularization

1 reference

12 December 2020

Factors promoting tumor angiogenesis

1 reference

12 December 2020

Treatment of metastatic cancer with tetrathiomolybdate, an anticopper, antiangiogenic agent: Phase I study.

1 reference

12 December 2020

Angiogenesis and Cancer Control: From Concept to Therapeutic Trial

1 reference

12 December 2020

Copper control as an antiangiogenic anticancer therapy: lessons from treating Wilson's disease

1 reference

12 December 2020

Copper deficiency induced by tetrathiomolybdate suppresses tumor growth and angiogenesis.

1 reference

12 December 2020

Tetrathiomolybdate therapy protects against bleomycin-induced pulmonary fibrosis in mice

1 reference

12 December 2020

Treatment of Wilson Disease With Ammonium Tetrathiomolybdate

1 reference

12 December 2020

Metabolic effects of molybdenum toxicity in the rat

1 reference

12 December 2020

Lung cytokine production in bleomycin-induced pulmonary fibrosis

1 reference

12 December 2020

1 reference

12 December 2020

Inactivation of human fibroblast growth factor-1 (FGF-1) activity by interaction with copper ions involves FGF-1 dimer formation induced by copper-catalyzed oxidation

1 reference

12 December 2020

Interrelations of copper, molybdenum and sulfate sulfur in nutrition

1 reference

12 December 2020

Influence of excess dietary molybdenum on rat and calf liver and heart enzymes

1 reference

12 December 2020

Cancer therapy with tetrathiomolybdate: antiangiogenesis by lowering body copper--a review

1 reference

12 December 2020

Inhibition of angiogenesis and tumor growth in the brain. Suppression of endothelial cell turnover by penicillamine and the depletion of copper, an angiogenic cofactor

1 reference

12 December 2020

Initial therapy of patients with Wilson's disease with tetrathiomolybdate

1 reference

12 December 2020

Some preliminary observations on the effect of molybdenum on copper metabolism in herbivorous animals

1 reference

12 December 2020

Human vascular permeability factor. Isolation from U937 cells

1 reference

12 December 2020

A convenient method for the treatment of chronic copper poisoning in sheep using subcutaneous ammonium tetrathiomolybdate

1 reference

12 December 2020

Hypocupremia Induced by Zinc Therapy in Adults

1 reference

12 December 2020

Reversible pancytopenia secondary to treatment with tetrathiomolybdate.

1 reference

12 December 2020

Use of ammonium tetrathiomolybdate in the treatment of copper poisoning in sheep

1 reference

12 December 2020

Management of Wilson's disease with zinc sulphate. Experience in a series of 27 patients

1 reference

12 December 2020

Copper Regulation of Ceruloplasmin in Copper-Deficient Rats

1 reference

12 December 2020

Tumor angiogenesis: therapeutic implications

1 reference

12 December 2020

Effect of dietary molybdenum and sulfate upon copper metabolism in sheep

1 reference

12 December 2020

Role of prostaglandin E1 and copper in angiogenesis

1 reference

12 December 2020

Ceruloplasmin, copper ions, and angiogenesis

1 reference

12 December 2020

99Mo metabolism in sheep after the intravenous injection of [99Mo] thiomolybdates

1 reference

12 December 2020

X-ray microanalysis of liver and kidney in copper loaded sheep with and without thiomolybdate administration

1 reference

12 December 2020

Oral zinc therapy for Wilson's disease

1 reference

12 December 2020

Some studies on the metabolism and the effects of 99Mo- and 35S-labelled thiomolybdates after intravenous infusion in sheep

1 reference

12 December 2020

Copper metabolism in rats given di- or trithiomolybdates

1 reference

12 December 2020

Copper and molybdenum absorption by rats given ammonium tetrathiomolybdate

1 reference

12 December 2020

Effects of molybdate, sulfide, and tetrathiomolybdate on copper metabolism in rats

1 reference

12 December 2020

Intravenous administration of thiomolybdate for the prevention and treatment of chronic copper poisoning in sheep

1 reference

12 December 2020

An investigation of the effects of intravenous administration of thiomolybdate on copper metabolism in chronic Cu-poisoned sheep

1 reference

12 December 2020

Oral zinc in Wilson's disease

1 reference

12 December 2020

Copper, lysyl oxidase, and extracellular matrix protein cross-linking

1 reference

12 December 2020

1 reference

12 December 2020

Lack of a recommended dietary allowance for copper may be hazardous to your health

1 reference

12 December 2020

Treatment of Wilson disease with ammonium tetrathiomolybdate: III. Initial therapy in a total of 55 neurologically affected patients and follow-up with zinc therapy

1 reference

12 December 2020

10.1111/J.1582-4934.2003.TB00198.X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6740133&resulttype=core&format=json

12 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6740133&resulttype=core&format=json

12 May 2020

1 reference